Cargando…

Long-Noncoding RNA FGD5-AS1 Enhances the Viability, Migration, and Invasion of Glioblastoma Cells by Regulating the miR-103a-3p/TPD52 Axis

PURPOSE: This study was designed to explore the functional role of FYVE, RhoGEF, and PH domain containing 5 antisense RNA 1 (FGD5-AS1) and the underlying regulatory mechanism in the progression of glioblastoma (GBM). MATERIALS AND METHODS: FGD5-AS1 expression was analyzed in The Cancer Genome Atlas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Daoqing, Ji, Zhengang, Xue, Pengfei, Guo, Shengfu, Jia, Qingbin, Sun, Hanyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425657/ https://www.ncbi.nlm.nih.gov/pubmed/32848452 http://dx.doi.org/10.2147/CMAR.S253467

Ejemplares similares

Long Noncoding RNA DSCAM-AS1 Facilitates Proliferation and Migration of Hemangioma Endothelial Cells by Targeting miR-411-5p/TPD52 Axis
por: Wang, Yulong, et al.
Publicado: (2022)

Retracted: Long Noncoding RNA DSCAM-AS1 Facilitates Proliferation and Migration of Hemangioma Endothelial Cells by Targeting miR-411-5p/TPD52 Axis
por: International, BioMed Research
Publicado: (2023)

Hsa_circ_0007637 Facilitates Nasopharyngeal Carcinoma Progression by Sponging miR-636/TPD52 Axis
por: Wang, Yihong, et al.
Publicado: (2021)

Long Non-Coding RNA HULC Promotes Cervical Cancer Cell Proliferation, Migration and Invasion via miR-218/TPD52 Axis
por: Lu, Wenjun, et al.
Publicado: (2020)

Hsa_circ_0084927 Regulates Cervical Cancer Advancement via Regulation of the miR-634/TPD52 Axis
por: Shi, Peijing, et al.
Publicado: (2020)

Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis
por: Zhang, Hui, et al.
Publicado: (2021)

Downregulation of MicroRNA-449 Promotes Migration and Invasion of Breast Cancer Cells by Targeting Tumor Protein D52 (TPD52)
por: Zhang, Zhiling, et al.
Publicado: (2017)

Tumor protein D52 (TPD52) affects cancer cell metabolism by negatively regulating AMPK
por: Chen, Yali, et al.
Publicado: (2022)

Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2015)

MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52
por: Li, Yuanbo, et al.
Publicado: (2022)

Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis
por: Lv, Jian, et al.
Publicado: (2021)

TPD36 - A test program for the TPD modules
por: Fagerstrom, J
Publicado: (1990)

Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma
por: Kumamoto, Tomohiro, et al.
Publicado: (2016)

Retracted: MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52
por: Engineering, Journal of Healthcare
Publicado: (2023)

TPD52L2 Is a Prognostic Biomarker and Correlated With Immune Infiltration in Lung Adenocarcinoma
por: Zhong, Anyuan, et al.
Publicado: (2021)

Cross talk of tumor protein D52 (TPD52) with KLF9, PKCε, and MicroRNA 223 in ovarian cancer
por: Khan, Khushbukhat, et al.
Publicado: (2023)

Knockdown of lncRNA PCAT6 Enhances Radiosensitivity in Triple-Negative Breast Cancer Cells by Regulating miR-185-5p/TPD52 Axis
por: Shi, Rui, et al.
Publicado: (2020)

The TPD Calibration program
por: Strom, D, et al.
Publicado: (1987)

Anti-osteosarcoma effect of antiserum against cross antigen TPD52 between osteosarcoma and Trichinella spiralis
por: Yue, Tao-Tao, et al.
Publicado: (2021)

miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52
por: Chen, Hong, et al.
Publicado: (2016)

MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
por: Byrne, Jennifer A, et al.
Publicado: (2010)

The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis
por: Li, Jingwen, et al.
Publicado: (2017)

Androgen receptor suppresses lung cancer invasion and increases cisplatin response via decreasing TPD52 expression
por: Liu, Shiqing, et al.
Publicado: (2023)

miR-139-5p Regulates Proliferation, Apoptosis, and Cell Cycle of Uterine Leiomyoma Cells by Targeting TPD52 [Retraction]
Publicado: (2023)

Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway
por: Zhao, Zhenhua, et al.
Publicado: (2017)

miR-139-5p Regulates Proliferation, Apoptosis, and Cell Cycle of Uterine Leiomyoma Cells by Targeting TPD52 [Expression of Concern]
Publicado: (2020)

Long Noncoding RNA FGD5-AS1 Promotes Glioma Cell Proliferation, Migration and Invasion by Regulating wnt/β-Catenin Pathway
por: Zhao, Jun Bo, et al.
Publicado: (2020)

Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ-based quantitative proteomics analysis
por: Ren, Hongyue, et al.
Publicado: (2019)

Tissue microarray profiling and integrative proteomics indicate the modulatory potential of Maytenus royleanus in inhibition of overexpressed TPD52 in prostate cancers
por: Shabbir, Maria, et al.
Publicado: (2021)

The Antitumor Effect of TPD52L2 Silencing on Oxaliplatin-Resistant Gastric Carcinoma Is Related to Endoplasmic Reticulum Stress In Vitro
por: Zhang, Yu, et al.
Publicado: (2022)

Long Noncoding RNA FGD5-AS1 Promotes Glioma Cell Proliferation, Migration and Invasion by Regulating Wnt/β-Catenin Pathway [Retraction]
Publicado: (2023)

EMBR-21. CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY
por: Delaidelli, Alberto, et al.
Publicado: (2021)

PATH-03. Clinically Tractable Outcome Prediction of Group 3/4 Medulloblastoma Based on TPD52 Immunohistochemistry: a Multicohort Study
por: Delaidelli, Alberto, et al.
Publicado: (2022)

TPD test programs Instructions on how to use them
por: Thomas, J
Publicado: (1987)

TPD52L1-ROS1 Rearrangement as a New Acquired Resistance Mechanism to Osimertinib That Responds to Crizotinib in Combination With Osimertinib in Lung Adenocarcinoma
por: Xu, Caihua, et al.
Publicado: (2020)

Draft Whole-Genome Sequences of Xylella fastidiosa subsp. fastidiosa Strains TPD3 and TPD4, Isolated from Grapevines in Hou-li, Taiwan
por: Castillo, Andreina I., et al.
Publicado: (2019)

A novel TPD52L2-ROS1 gene fusion expanding the molecular alterations in inflammatory myofibroblastic tumor: case report and literature review
por: Liu, Xuguang, et al.
Publicado: (2023)

Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
por: Wang, Huifang, et al.
Publicado: (2023)

Delayed recruiting of TPD52 to lipid droplets – evidence for a “second wave” of lipid droplet-associated proteins that respond to altered lipid storage induced by Brefeldin A treatment
por: Chen, Yuyan, et al.
Publicado: (2019)

The SuperFGD Prototype Charged Particle Beam Tests
por: Blondel, A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1cl5ccd2gr6trinem4rlekolrl